Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2019 Earnings Conference Call May 13, 2019 4:30 PM ET Company Participants AJ Bergmann - CFO Linda Marbán - President and CEO Conference Call Participants Joe Pantginis - H.C. Wainwright Jason McCarthy - Maxim Group Operator Welcome to Capricor Therapeutics First Quarter 2019 Conference Call. My name is Chris and I'll be your operator for today's call. [Operator Instructions] As a reminder this call will be recorded. I would now like to turn the call over to Capr ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K þ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the fiscal year ended December 31, 2018 or ¨ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the transition period from to Commission File Number: 001-34058 CAPRICOR THERAPEUTICS, INC. (Exact Name Of Registrant As Specified In Its Charter) Delaware 88-0363465 (State or other jurisdiction of in ...

Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q4 2018 Earnings Conference Call March 28, 2019 4:30 PM ET Corporate Participants AJ Bergmann - Chief Financial Officer Linda Marbán - President & Chief Executive Officer Conference Call Participants Jason McCarthy - Maxim Group Joe Pantginis - H.C. Wainwright Tim Chiang - BTIG Operator Welcome to Capricorn Therapeutics Fourth Quarter and Full Year 2018 Conference Call. My name is Morin and I'll be your operator for today's call. At this time all participants are in ...